tradingkey.logo

Anbio Biotechnology

NNNN
查看詳細走勢圖
25.650USD
+1.590+6.61%
收盤 02/06, 16:00美東報價延遲15分鐘
1.13B總市值
416.53本益比TTM

Anbio Biotechnology

25.650
+1.590+6.61%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+6.61%

5天

+17.07%

1月

-21.03%

6月

-49.76%

今年開始到現在

-14.70%

1年

0.00%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Anbio Biotechnology新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Anbio Biotechnology簡介

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
公司代碼NNNN
公司Anbio Biotechnology
CEOLau (Michael)
網址https://anbiobiotechnology.com/
KeyAI